Form 4 for PGNY Progyny, Inc.

Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001179110-21-008591 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-09-03	2021-09-01	PGNY	Livingston Mark S.	CFO	A - Grant	$0.00	+75.0K	90.3K	+489%	$0
D	2021-09-03	2021-09-01	PGNY	Livingston Mark S.	CFO	A - Grant	$0.00	+250.0K	250.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-01	A	A	75,000	$0.00	90,348	D	—	—	(F1) Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. (F2) Represents a grant of RSUs made pursuant to the Issuer's 2019 Equity Incentive Plan. One fourth (1/4th) of the shares subject to the grant shall vest on September 1, 2022 and one-sixteenth (1/16th) of the shares subject to the grant shall vest each quarter thereafter through September 1, 2025, subject to the reporting person's continued service through each such date.
2	Derivative	Employee Stock Option (Right to Buy)	2021-09-01	A	A	250,000	$0.00	250,000	D	$56.29 · — to 2031-08-31	250,000 Common Stock	(F3) Represents a grant of employee stock options made pursuant to the Issuer's 2019 Equity Incentive Plan. One fourth (1/4th) of the shares subject to the grant shall vest on September 1, 2022 and one-sixteenth (1/16th) of the shares subject to the grant shall vest each quarter thereafter through September 1, 2025, subject to the reporting person's continued service through each such date.